Durability of the Mumps Antibody Response After the Third Dose of MMR Vaccine
By 9-11 years after receipt of MMR3, many participants had mumps antibody levels that predicted susceptibility to infection, comparable to those observed before receipt of MMR3. The antibody titers to Genotype G remained consistently lower than the titers to the vaccine strain.
Authors
- David L. McClure (ORCID: https://orcid.org/0000-0001-8470-7190)
- Nina B. Masters (ORCID: https://orcid.org/0000-0002-3155-6058)
- Stephen N. Crooke (ORCID: https://orcid.org/0000-0002-4711-5767)
- Sara Mercader (ORCID: https://orcid.org/0000-0003-3567-0381)
- Sun B. Sowers (ORCID: https://orcid.org/0000-0001-5525-5252)
- Heather Colley (ORCID: https://orcid.org/0000-0003-3604-4075)
- Carole J. Hickman (ORCID: https://orcid.org/0000-0002-4047-8151)
- Huong Q. Nguyen (ORCID: https://orcid.org/0000-0003-2725-6439)
- Mona Marin (ORCID: https://orcid.org/0000-0001-9705-0511)
Institutions
- Centers for Disease Control and Prevention (US)
- National Center for Immunization and Respiratory Diseases (US)
- Marshfield Clinic (US)
Publication Details
- Journal
- The Journal of Infectious Diseases
- Published
- 2025-11-14
- DOI
- https://doi.org/10.1093/infdis/jiaf520
- Citations
- 1
- Primary Topic
- Virology and Viral Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- Seqirus
- Centers for Disease Control and Prevention